Launched in 2016, IDDO builds on and incorporates the pioneering work of the WorldWide Antimalarial Resistance Network (WWARN), a collaborative data-sharing framework begun in 2009 that proved it was possible to produce policy-changing scientific evidence from historical data.
IDDO currently has eight active areas of research work, with more in development, and collaborates with researchers and partners globally. Find out more via the links below.
Substandard and falsified (SF) medicines negate the multiple benefits of modern healthcare, so good quality medical products are essential. By sharing global expertise and collating information, IDDO’s Medicine Quality Research Group strengthens knowledge of the scale of the problem and raises vital awareness among key stakeholders.
IDDO brings together a broad range of expertise from across the infectious diseases research community. Below are the team members working on the Chagas Disease research theme based at IDDO. The theme is coordinated by IDDO and the Drugs for Neglected Diseases initiative’s Latin America Office.